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ABSTRACT 
 
Drug Utilization Study of Vitiligo Patients  
(Study at Cosmetic Dermatology Division of Dermato Venerology 
Departement Dr. Soetomo Teaching Hospital Surabaya 2012-2017) 
 
Nina Sapti Humida 
 
 Vitiligo is a hypopigmentation disorder characterized by progressive 
melanocyte loss that manifest into white macules of the skin, mucosa, or hair. 
Prevalence of vitiligo in Asia is only known 8,8% in India and 0,09-0,019% 
in China, while in Indonesia has not found certain. Vitiligo is treated by 
inhibiting the immune response so reducing melanocyte damage and 
enhancing the epidermal repopulation by melanocyte either by stimulating 
the recovery of damaged melanocytes, reactivating residual melanocyte or 
stimulating melanocyte migration such as corticosteroids, calcineurin 
inhibitors, antioxidants, phototherapy, and additional therapies such as 
sunscreen. 
 This study aimed to analyze the utilization of drug in vitiligo including 
type drug, route of administration, dose, frequency, length of therapy in 
vitiligo and also identify their adverse effect. This study was retrospective 
method at period 1 January 2012 until 31 December 2017. Furthermore, this 
study has been reviewed by The Ethic Committee of Dr. Soetomo Teaching 
Hospital Surabaya. 
 There were 100 patients who met the sample criteria. The result 
showed that 97% patients received corticosteroid topical, 94% patients 
received sunscreen, 7% patients received calcineurin inhibitor topical, and 
23% received additional therapy. The type treatment given is varied in patient 
depend on their condition.  
 From this study, the utilization of treatment in vitiligo was appropriate 
with condition of each patient. Further study on vitiligo treatment needed 
follow up to identify its efficacy and DRPs.  
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